| Mary F Burgesser-howard Md | |
|
1420 W Exchange Pkwy Ste 120 Allen TX 75013-4696 | |
| (972) 521-6210 | |
| Not Available |
| Full Name | Mary F Burgesser-howard Md |
|---|---|
| Speciality | General Practice |
| Location | 1420 W Exchange Pkwy Ste 120, Allen, Texas |
| Authorized Official Name and Position | Jeff Barber (MGR) |
| Authorized Official Contact | 8063556593 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Mary F Burgesser-howard Md Po Box 8337 Amarillo TX 79114-8337 Ph: (806) 355-6593 | Mary F Burgesser-howard Md 1420 W Exchange Pkwy Ste 120 Allen TX 75013-4696 Ph: (972) 521-6210 |
| NPI Number | 1346737046 |
|---|---|
| Provider Enumeration Date | 04/18/2018 |
| Last Update Date | 04/18/2018 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346737046 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | (* (Not Available)) | Secondary |
| 208D00000X | General Practice | K4005 (Texas) | Primary |
News Archive
CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the publication of new data in the journal Nature Biotechnology by Alnylam scientists and collaborators from Tekmira Pharmaceuticals Corporation, AlCana Technologies, Inc., and The University of British Columbia (UBC). The new study employed a rational design approach for the discovery of novel lipids that can be incorporated into lipid nanoparticles (LNPs) for systemic delivery of RNAi therapeutics.
An international team of Parkinson's disease researchers has shown that a potential new drug is effective at treating patients in the early stages of Parkinson's and may even slow the progression of the disease. The results from the Parkinson Study Group are in the April 19 issue of the Archives of Neurology.
A skin cancer prevention program called SunSmart may have contributed to a recent reduction in melanoma among younger residents of Melbourne, according to a study published October 8 in the open-access journal PLOS Medicine by Suzanne Dobbinson of Cancer Council Victoria in Australia, and colleagues.
› Verified 2 days ago
Andala Medical Texas Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 Raintree Cir Ste 201, Allen, TX 75013 Phone: 210-862-7246 | |
American Physician Housecalls Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 West Boyd Drive, Suite A, Allen, TX 75013 Phone: 214-644-0967 Fax: 469-893-1938 | |
Cliff Omoregie Md Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 973 Pembrook Ln, Allen, TX 75013 Phone: 888-212-4243 | |
Karmali Consulting Co Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1001 Raintree Cir, Allen, TX 75013 Phone: 972-908-2000 | |
Ali A Bahrani Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1213 Windmere Way, Allen, TX 75013 Phone: 972-697-3248 | |
North Texas Nurse Practitioners Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 906 W Mcdermott Dr, Suite 116, Pmb 348, Allen, TX 75013 Phone: 214-315-6021 Fax: 214-383-0089 | |
Medical Diagnostic Services, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 190 E Stacy Rd Ste 306-228, Allen, TX 75002 Phone: 469-250-0273 |